MEGAN LARSEN: Open Payments
NPI 1043231376 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 40 payments from 14 companies in 2025. Trend: 2023 $1,351 · 2024 $1,398 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $174 |
| Lilly USA, LLC | 7 | $149 |
| AstraZeneca Pharmaceuticals LP | 5 | $131 |
| Merck Sharp & Dohme LLC | 4 | $122 |
| Daiichi Sankyo Inc. | 4 | $105 |
| Gilead Sciences, Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $55 |
| ACCORD HEALTHCARE, INC. | 2 | $49 |
| Caris MPI, Inc. | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $22 |
Products named: ENHERTU, KISQALI, VERZENIO, KEYTRUDA, Trodelvy, ELAHERE, Camcevi, MI CANCER SEEK.
Industry payments across CA — which companies pay providers there.
